{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:59:17Z","timestamp":1790629157784,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.ejca.2013.02.005","type":"journal-article","created":{"date-parts":[[2013,3,13]],"date-time":"2013-03-13T02:21:29Z","timestamp":1363141289000},"page":"1876-1881","source":"Crossref","is-referenced-by-count":19,"title":["Amplification but not translocation of anaplastic lymphoma kinase is a frequent event in oesophageal cancer"],"prefix":"10.1016","volume":"49","author":[{"given":"Sebastian F.","family":"Schoppmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berthold","family":"Streubel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Birner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejca.2013.02.005_b0005","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/sj.onc.1200849","article-title":"Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system","volume":"14","author":"Iwahara","year":"1997","journal-title":"Oncogene"},{"issue":"5151","key":"10.1016\/j.ejca.2013.02.005_b0010","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1126\/science.8122112","article-title":"Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin\u2019s lymphoma","volume":"263","author":"Morris","year":"1994","journal-title":"Science"},{"issue":"7153","key":"10.1016\/j.ejca.2013.02.005_b0015","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature05945","article-title":"Identification of the transforming EML4\u2013ALK fusion gene in non-small-cell lung cancer","volume":"448","author":"Soda","year":"2007","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.ejca.2013.02.005_b0020","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1158\/1078-0432.CCR-10-2798","article-title":"Role of ERK\u2013BIM and STAT3-survivin signaling pathways in ALK inhibitor-induced apoptosis in EML4\u2013ALK-positive lung cancer","volume":"17","author":"Takezawa","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.ejca.2013.02.005_b0025","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm1249","article-title":"Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target","volume":"11","author":"Chiarle","year":"2005","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.ejca.2013.02.005_b0030","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.2174\/156802611795589593","article-title":"The ALK gene, an attractive target for inhibitor development","volume":"11","author":"Tartari","year":"2011","journal-title":"Curr Top Med Chem"},{"issue":"14","key":"10.1016\/j.ejca.2013.02.005_b0035","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1158\/1078-0432.CCR-11-2393","article-title":"Crizotinib for ALK-rearranged non-small cell lung cancer: a new targeted therapy for a new target","volume":"18","author":"Gandhi","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.ejca.2013.02.005_b0040","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1440-1746.2009.05824.x","article-title":"Epidemiology of esophageal cancer: orient to occident. Effects of chronology, geography and ethnicity","volume":"24","author":"Hongo","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"issue":"44","key":"10.1016\/j.ejca.2013.02.005_b0045","doi-asserted-by":"crossref","first-page":"7104","DOI":"10.3748\/wjg.v12.i44.7104","article-title":"Identification of squamous cell carcinoma associated proteins by proteomics and loss of beta tropomyosin expression in esophageal cancer","volume":"12","author":"Jazii","year":"2006","journal-title":"World J Gastroenterol"},{"issue":"8","key":"10.1016\/j.ejca.2013.02.005_b0050","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00109-007-0159-4","article-title":"Proteomic profiling of proteins dysregulated in Chinese esophageal squamous cell carcinoma","volume":"85","author":"Du","year":"2007","journal-title":"J Mol Med (Berl)"},{"issue":"12","key":"10.1016\/j.ejca.2013.02.005_b0055","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1097\/PAS.0b013e3181f8be17","article-title":"Expression of Her-2 in carcinomas of the esophagus","volume":"34","author":"Schoppmann","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.ejca.2013.02.005_b0060","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1158\/1078-0432.CCR-09-2845","article-title":"A novel, highly sensitive antibody allows for the routine detection of ALK-rearranged lung adenocarcinomas by standard immunohistochemistry","volume":"16","author":"Mino-Kenudson","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.ejca.2013.02.005_b0065","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10585-012-9475-3","article-title":"Phosphorylation of signal transducer and activator of transcription 3 (STAT3) correlates with Her-2 status, carbonic anhydrase 9 expression and prognosis in esophageal cancer","volume":"29","author":"Schoppmann","year":"2012","journal-title":"Clin Exp Metastasis"},{"issue":"Pt 15","key":"10.1016\/j.ejca.2013.02.005_b0070","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1242\/jcs.01183","article-title":"ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth","volume":"117","author":"Motegi","year":"2004","journal-title":"J Cell Sci"},{"issue":"4","key":"10.1016\/j.ejca.2013.02.005_b0075","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00408-012-9391-y","article-title":"ALK-mutated non-small-cell lung cancer: a new strategy for cancer treatment","volume":"190","author":"Cabezon-Gutierrez","year":"2012","journal-title":"Lung"},{"issue":"2","key":"10.1016\/j.ejca.2013.02.005_b0080","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0002-9440(10)64550-6","article-title":"TPM3\u2013ALK and TPM4\u2013ALK oncogenes in inflammatory myofibroblastic tumors","volume":"157","author":"Lawrence","year":"2000","journal-title":"Am J Pathol"},{"issue":"15","key":"10.1016\/j.ejca.2013.02.005_b0085","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.1158\/1078-0432.CCR-10-2809","article-title":"High ALK receptor tyrosine kinase expression supersedes ALK mutation as a determining factor of an unfavorable phenotype in primary neuroblastoma","volume":"17","author":"Schulte","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"18","key":"10.1016\/j.ejca.2013.02.005_b0090","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMoa1006448","article-title":"Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer","volume":"363","author":"Kwak","year":"2010","journal-title":"N Engl J Med"},{"issue":"12 Pt 1","key":"10.1016\/j.ejca.2013.02.005_b0095","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1158\/1535-7163.MCT-07-0365","article-title":"Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma","volume":"6","author":"Christensen","year":"2007","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"10.1016\/j.ejca.2013.02.005_b0100","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.lungcan.2012.05.093","article-title":"Multiparametric molecular characterization of pulmonary sarcomatoid carcinoma reveals a nonrandom amplification of anaplastic lymphoma kinase (ALK) gene","volume":"77","author":"Pelosi","year":"2012","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2013.02.005_b0105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/JTO.0b013e3181fb7cd6","article-title":"Increased ALK gene copy number and amplification are frequent in non-small cell lung cancer","volume":"6","author":"Salido","year":"2011","journal-title":"J Thorac Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2013.02.005_b0110","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/jnci\/djr553","article-title":"ALK gene amplified in most inflammatory breast cancers","volume":"104","author":"Tuma","year":"2012","journal-title":"J Natl Cancer Inst"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804913001135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804913001135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T04:52:20Z","timestamp":1539838340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804913001135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0959804913001135"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2013.02.005","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}